Senolyticsreview2022

Targeting cellular senescence to combat cancer and ageing.

Molecular oncology

confidence

Key findings

Review of senescence's context-dependent role in ageing and cancer; discusses targeting senescence for cancer and healthy ageing; no clinical/biological endpoints reported.

View source on PubMed (PMID 35674055) ↗

Sample size
N/A
Population
Not applicable (review article)
Dosing
N/A
Duration
N/A
Route
N/A
Blinding
not_reported
Controls
not_reported
Drug class
senolytic class
Full abstract

Senescence is a complex cellular process that is implicated in various physiological and pathological processes. It is characterized by a stable state of cell growth arrest and by a secretome of diverse pro-inflammatory factors, chemokines and growth factors. In this review, we summarize the context-dependent role of cellular senescence in ageing and in age-related diseases, such as cancer. We discuss current approaches to targeting senescence to develop therapeutic strategies to combat cancer and to promote healthy ageing, and we outline our vision for future research directions for senescence-based interventions in these fields.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.